肿瘤急症

doi:10.3969/j.issn.1002-1949.2018.03.020

摘要
图/表
参考文献(78)
相关文章 (15)

全文: PDF (600 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要肿瘤急症发生在癌症患者发病以及治疗的每一个阶段，医生要识别这些急症并能够进行适当的治疗。肿瘤急症对临床医生来说是一个挑战，因为它涉及多个学科诊疗，并且需要快速干预，以避免患者死亡或严重的永久性损伤，最终目标是将管理肿瘤患者的风险降到最低。本文列举了5个常见的肿瘤急症情况,包括上腔静脉综合征(SVCS)、恶性脊髓压迫(MSCC)、颅内压增高、静脉血栓栓塞(VTE)及高钙血症。初步讨论肿瘤急症的发病率、机制、临床特征、诊断以及治疗情况。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张洁
	公保才旦
	王伟
	陈松

关键词 ：肿瘤, 急症, 上腔静脉综合征(SVCS), 恶性脊髓压迫(MSCC), 静脉血栓栓塞(VTE)

收稿日期: 2017-11-03

通讯作者: 公保才旦（1954-），男，主任医师，副院长，E-mail:qhxngongbao@Aliyun-com。

作者简介: 张洁（1972-），女，副主任医师，E-mail：zhangjie19721031@126.com。

引用本文:

张洁，公保才旦，王伟，陈松. 肿瘤急症 [J]. 中国急救医学, 2018, 38(3): 263-268.
Zhang Jie, Gongbao Cai-dan, Wang Wei, Chen Song. Oncology emergencies . Chinese Journal of Critical Care Medicine, 2018, 38(3): 263-268.

链接本文:

http://www.cnemergency.org.cn/CN/10.3969/j.issn.1002-1949.2018.03.020 或 http://www.cnemergency.org.cn/CN/Y2018/V38/I3/263

［1］Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology［J］. Medicine (Baltimore), 2006, 85(1): 37-42. ［2］Parish JM, Marschke RF Jr, Dines DE, et al. Etiologic considerations in superior vena cava syndrome［J］. Mayo Clin Proc, 1981, 56(7):407-413. ［3］Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes［J］. N Engl J Med, 2007, 356(18):1862-1869. ［4］Armstrong BA, Perez CA, Simpson JR, et al. Role of irradiation in the management of superior vena cava syndrome［J］. Int J Radiat Oncol Biol Phys, 1987, 13（4）:531-539. ［5］Pluta E, Blecharz P, Reinfuss M, et al. Superior vena cava syndrome in patients with lung cancer - the role of radiotherapy: Part Ⅱ. Efficacy, complications and prognostic factors［J］. Onkologia I Radioterapia, 2011, 17(3):41-46 ［6］Beeson MS, Port JL. Superior vena cava syndrome［J］. Encyclopedia of Diagnostic Imaging, 2006, 233(5):1775. ［7］Kim HJ, Kim HS, Chung SH. CT diagnosis of superior vena cava syndrome: importance of collateral vessels［J］. AJR Am J Roentgenol, 1993, 161（3）:539-542. ［8］Mineo TC, Ambrogi V, Nofroni I, et al. Mediastinoscopy in superior vena cava obstruction: analysis of 80 consecutive patients［J］. Ann Thorac Surg, 1999, 68（1）:223-226. ［9］Hossen MM, Rabbani R, Hasan M. Oncologic Emergencies［J］. American Family Physician, 2014, 31(3):104-114. ［10］Krimsky WS, Behrens RJ, Kerkvliet GJ. Oncologic emergencies for the internist［J］. Cleve Clin J Med, 2002, 69（3）:209-210, 213-214, 216-217. ［11］Jahangiri M, Goldstraw P. The role of mediastinoscopy in superior vena caval obstruction［J］. Ann Thorac Surg, 1995, 59（2）:453-455. ［12］Haffy BG, Wilson LD. Palliation and oncologic emergencies［M］// Handbook of radiation oncology. Jones And Bartlett Publishers, 2009:159-172. ［13］Yu JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome-〖JP〗a proposed classification system and algorithm for management［J］. J Thorac Oncol, 2008, 3（8）:811-814. ［14］MT Mccurdy, Shanholtz CB. Oncologic emergencies［J］. Crit Care Med, 2012, 40(7):2212-2222. ［15］Ganeshan A, Hon LQ, Warakaulle DR, et al. Superior vena caval stenting for SVC obstruction: current status［J］. Eur J Radiol, 2009, 71（2）:343-349. ［16］Marcy PY, Magné N, Bentolila F, et al. Superior vena cava obstruction: Is stenting necessary［J］. Support Care Cancer, 2001, 9（2）:103-107. ［17］Ecker RD, Endo T, Wetjen NM, et al. Diagnosis and treatment of vertebral column metastases［J］.Mayo Clinic Proc, 2005, 80(9):1177-1186. ［18］Bach F, Larsen BH, Rohde K, et al. Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression［J］. Acta Neurochir (Wien), 1990, 107(1-2):37-43. ［19］Loblaw DA, Smith K, Lockwood G, et al. The Princess Margaret Hospital experience of malignant spinal cord compression［C］. Proc Am Soc Clin Oncol, 2003, 22: 119. ［20］Schiff D. Spinal cord compression［J］. Neurolclin, 2003, 21(1): 67-86. ［21］Loblaw DA, Laperriere NJ, Mackillop WJ. A population-based study of malignant spinal cord compression in Ontario［J］. Clin Oncol(R Coll Radiol), 2003, 15(4): 211-217. ［22］Jacobs WB, Perrin RG. Evaluation and treatment of spinal metastases: an overview［J］. Neurosurgical Focus, 2001, 11(6):e10. ［23］Prasad D, Schiff D. Malignant spinal-cord compression［J］. Lancet Oncol, 2005, 6(1): 15-24. ［24］Schiff D, Batchelor T, Wen PY. Neurologic emergencies in cancer patients［J］. Neurol Clin, 1998, 16(2): 449-483. ［25］Quint DJ. Indications for emergent MRI of the central nervous system［J］. JAMA, 2000, 283(7): 853-855. ［26］Husband DJ, Grant KA, Romaniuk CS. MRI in the diagnosis and treatment of suspected malignant spinal cord compression［J］. Br J Radiol, 2001, 74(877): 15-23. ［27］Portenoy RK, Galer BS, Salamon O, et al. Identification of epidural neoplasm. Radiography and bone scintigraphy in the symptomatic and asymptomatic spine［J］. Cancer, 1989, 64(11): 2207-2213. ［28］Yeung SCJ, Escalante CP. Oncologic emergencies［M］. Am J Nursing, 1983, 83(9):1283-1285. ［29］Loblaw DA, Perry J, Chambers A, et al. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative’s Neuro-Oncology Disease Site Group［J］. J Clin Oncol, 2005, 23(9): 2028-2037. ［30］Bilsky MH, Lis E, Raizer J, et al. The diagnosis and treatment of metastatic spinal tumor［J］. Oncologist, 1999, 4(6): 459-469. ［31］Brigden ML. Hematologic and oncologic emergencies. Doing the most good in the least time［J］. Postgraduate Medicine, 2001, 109(3): 143-146. ［32］Kvale PA, Simoff M, Prakash UB. Lung cancer. Palliative care［J］. Chest, 2003, 123(1suppl): 284S-311S. ［33］Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial［J］. Lancet, 2005, 366(9486): 643-648. ［34］Klimo P Jr, Schmidt MH. Surgical management of spinal metastases［J］. Oncologist, 2004, 9(2): 188-196. ［35］Halfdanarson TR, Hogan WJ, Moynihan TJ. Oncologic emergencies: diagnosis and treatment［C］. Mayo Clinic Proceedings, Elsevier, 2006, 81(6): 835-848. ［36］Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System［J］. J Clin Oncol, 2004, 22(14): 2865-2872. ［37］Behl D, Hendrickson AW, Moynihan TJ, et al. Oncologic emergencies［J］. Crit Care Clin, 2010, 26(1):181-205. ［38］Tosoni A, Ermani M, Brandes AA. The pathogenesis and treatment of brain metastases: a comprehensive review［J］. Crit Rev Oncol Hematol, 2004, 52(3): 199-215. ［39］Dunn LT. Raised intracranial pressure［J］. J Neurol Neurosurg Psychiatry, 2002, 73(suppl 1): i23-i27. ［40］Kaal EC, Vecht CJ. The management of brain edema in brain tumors［J］. Curr Opin Oncol, 2004, 16(6): 593-600. ［41］Christiaans MH, Kelder JC, Arnoldus EP, et al. Prediction of intracranial metastases in cancer patients with headache［J］. Cancer, 2002, 94(7): 2063-2068. ［42］Klos KJ, O’Neill BP. Brain metastases［J］. Neurologist, 2004, 10(1): 31-46. ［43］Nutt SH, Patchell RA. Intracranial hemorrhage associated with primary and secondary tumors［J］. Neurosurg Clin N Am, 1992, 3(3):591-599. ［44］Kaal EC, Nil CG, Vecht CJ. Therapeutic management of brain metastasis［J］. Lancet Neurol, 2005, 4(5):289-298. ［45］Jarden JO, Dhawan V, Moeller JR, et al. The time course of steroid action on blood-to-brain and blood-to-tumor transport of 82Rb: a positron emission tomographic study［J］. Ann Neurol, 1989, 25(3):239-245. ［46］Batchelor T, Deangelis LM. Medical management of cerebral metastases［J］. Neurosurg Clin N Am, 1996, 7(3):435-446. ［47］Peacock KH, Lesser GJ. Current therapeutic approaches in patients with brain metastases［J］. Curr Treat Options Oncol, 2006, 7(6):479-489. ［48］Lewis MA, Hendrickson AW, Moynihan TJ. Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment［J］. CA Cancer J Clin, 2011, 61(5):287-314.［49］Tsao MN, Lloyd NS, Wong RK, et al. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis［J］. Cancer Treat Rev, 2005, 31(4): 256-273. ［50］Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers［J］. Arch Intern Med, 2006, 166(4):458-464. ［51］Khorana AA, Francis CW, Culakova E, et al. Thromboembolism in hospitalized neutropenic cancer patients［J］. J Clin Oncol, 2006, 24(3):484-490. ［52］Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy［J］. J Thromb Haemost, 2007, 5(3):632-634. ［53］Falanga A, Zacharski L. Deep vein thrombosis in cancer: the scale of the problem and approaches to management［J］. Ann Oncol, 2005, 16(5):696-791. ［54］Seddighzadeh A, Shetty R, Goldhaber SZ. Venous thromboembolism in patients with active cancer［J］. Thromb Haemost, 2007, 98(3):656-661. ［55］Agnelli G, Verso M, Ageno W, et al. The MASTER registry on venous thromboembolism: description of the study cohort［J］. Thromb Res, 2008, 121(5):605-610. ［56］Linenberger ML. Catheter-related thrombosis: risks, diagnosis, and management［J］. J Natl Compr Canc Netw, 2006, 4(9):889-901. ［57］Carrier M, Lee AY, Bates SM, et al. Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients［J］. ThrombRes, 2008, 123(1):177-183. ［58］Rosovsky RP, Kuter DJ. Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis, and management［J］. Hematol Oncol Clin North Am, 2005, 19(1):183-202. ［59］Van Belle A, Büller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography［J］. JAMA, 2006, 295(2):172-179. ［60］Stein PD, Woodard PK, Weg JG, et al. Diagnostic pathways in acute pulmonary embolism: recommendations of The PIOPEDⅡInvestigators［J］. Radiology, 2007, 242(1):15-21. ［61］Mandalà M, Falanga A, Roila F. Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines［J］. Ann Oncol, 2011, 22(suppl_6):vi85-92. ［62］Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis［J］. Ann Surg, 1988, 208(2):227-240. ［63］Levine M, Hirsh J, Gent M, et al. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stageⅣbreast cancer［J］. Lancet, 1994, 343(8902):886-889. ［64］Stewart AF.Clinical practice. Hypercalcemia Associated with Cancer［J］. N Engl J Med, 2005, 352(4):373-379. ［65］Body JJ. Hypercalcemia of malignancy［J］. Semin Nephrol, 2004, 24(1):48-54. ［66］Ralston SH, Gallacher SJ, Patel U, et al. Cancer-associated hypercalcemia: morbidity and mortality: Clinical experience in 126 treated patients［J］. Ann Intern Med, 1990, 112(7):499-504. ［67］Wimalawansa SJ. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate［J］. Cancer, 1994, 73(8):2223-2230. ［68］Glass DA 2nd, Patel MS, Karsenty G. A new insight into the formation of osteolytic lesions in multiple myeloma［J］. N Engl J Med, 2003, 349(26):2479-2480. ［69］Seymour JF, Gagel RF. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin′s and non-Hodgkin′s lymphomas［J］. Blood, 1993, 82(5):1383-1394. ［70］Deftos LJ. Hypercalcemia in malignant and inflammatory diseases［J］. Endocrinol Metab Clin North Am, 2002, 31(1):141-158. ［71］Myers WP. Differential diagnosis of hypercalcemia and cancer［J］. CA Cancer J Clin, 1977, 27(5):258-272. ［72］John R, Oleesky D, Issa B, et al. Pseudohypercalcaemia in two patients with IgM paraproteinaemia［J］. Ann Clin Biochem, 1997, 34 (Pt 6):694-696. ［73］Ladenson JH, Lewis JW, McDonald JM, et al. Relationship of free and total calcium in hypercalcemic conditions［J］. J Clin Endocrinol Metab, 1979, 48(3):393-397. ［74］Stewart AF. Clinical practice. Hypercalcemia associated with cancer［J］. N Engl J Med, 2005, 352(4):373-379. ［75］Ratcliffe WA, Hutchesson AC, Bundred NJ, et al. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia［J］. Lancet, 1992, 339(8786):164-167. ［76］Santarpia L, Koch CA, Sarlis NJ. Hypercalcemia in cancer patients: pathobiology and management［J］. Horm Metab Res, 2010, 42(3):153-164. ［77］Koo WS, Jeon DS, Ahn SJ, et al. Calcium-free hemodialysis for the management of hypercalcemia［J］. Nephron, 1996, 72(3):424-428. ［78］3Rd VA, O′Neal W, Palermo V. Lethal hyperparathyroid crisis:hazards of phosphate administration［J］. Surgery, 1987, 102(6):941-948.